Strengthening ATMP Development In Europe: How BioServices Centers In France Enable Efficiency And Scalability

As developers of Advanced Therapy Medicinal Products (ATMPs) move from early-stage research to late-phase clinical trials and eventual commercialization, the complexities of biostorage, sample management, and regulatory-compliant logistics intensify. Effectively managing these critical elements is vital to maintaining product integrity, ensuring regulatory compliance, and facilitating smooth supply chain operations.

Cryoport Systems' BioServices Centers in Clermont-Ferrand and Pont-du-Château, France, offer a comprehensive platform for biostorage, sample processing, and regulatory support, tailored to meet the unique needs of ATMP clinical trials and commercial programs. In addition, to further enhance the ATMP supply chain infrastructure, we will expand our capabilities with the opening of a new Global Supply Chain Center in Paris in late 2025. This facility will streamline distribution across Europe, reinforcing our commitment to supporting the growing demands of the ATMP industry.